1. Home
  2. TRN vs RCUS Comparison

TRN vs RCUS Comparison

Compare TRN & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRN
  • RCUS
  • Stock Information
  • Founded
  • TRN 1933
  • RCUS 2015
  • Country
  • TRN United States
  • RCUS United States
  • Employees
  • TRN N/A
  • RCUS N/A
  • Industry
  • TRN Railroads
  • RCUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRN Industrials
  • RCUS Health Care
  • Exchange
  • TRN Nasdaq
  • RCUS Nasdaq
  • Market Cap
  • TRN 2.2B
  • RCUS 2.4B
  • IPO Year
  • TRN N/A
  • RCUS 2018
  • Fundamental
  • Price
  • TRN $26.49
  • RCUS $25.87
  • Analyst Decision
  • TRN Hold
  • RCUS Buy
  • Analyst Count
  • TRN 1
  • RCUS 8
  • Target Price
  • TRN $24.00
  • RCUS $27.63
  • AVG Volume (30 Days)
  • TRN 661.6K
  • RCUS 2.0M
  • Earning Date
  • TRN 10-30-2025
  • RCUS 10-28-2025
  • Dividend Yield
  • TRN 4.53%
  • RCUS N/A
  • EPS Growth
  • TRN N/A
  • RCUS N/A
  • EPS
  • TRN 1.14
  • RCUS N/A
  • Revenue
  • TRN $2,175,100,000.00
  • RCUS $240,000,000.00
  • Revenue This Year
  • TRN N/A
  • RCUS N/A
  • Revenue Next Year
  • TRN $10.16
  • RCUS N/A
  • P/E Ratio
  • TRN $21.47
  • RCUS N/A
  • Revenue Growth
  • TRN N/A
  • RCUS N/A
  • 52 Week Low
  • TRN $22.38
  • RCUS $6.50
  • 52 Week High
  • TRN $39.83
  • RCUS $26.04
  • Technical
  • Relative Strength Index (RSI)
  • TRN 52.56
  • RCUS 85.33
  • Support Level
  • TRN $24.76
  • RCUS $19.44
  • Resistance Level
  • TRN $26.77
  • RCUS $20.85
  • Average True Range (ATR)
  • TRN 0.61
  • RCUS 1.22
  • MACD
  • TRN 0.20
  • RCUS 0.42
  • Stochastic Oscillator
  • TRN 86.32
  • RCUS 93.96

About TRN Trinity Industries Inc.

Trinity Industries Inc. sells and leases railroad products and railcar maintenance services in North America. The company operates under the name TrinityRail in three main segments: railcar leasing and management services, which owns railcars and provides fleet management and administration services; rail products, which builds, sells, and modifies freight and tank railcars and their components; and all other, which sells highway products such as guardrail and other highway barriers. Customers include railroads, leasing companies, and shipping companies in agriculture, construction, consumer products, energy, and chemicals.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: